Welcome to our dedicated page for UNITEDHEALTH GROUP SEC filings (Ticker: UNH), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on UNITEDHEALTH GROUP's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into UNITEDHEALTH GROUP's regulatory disclosures and financial reporting.
McSweeney Erin reported disposition transactions in a Form 4 filing for UNH. The filing lists transactions totaling 153 shares at a weighted average price of $293.19 per share. Following the reported transactions, holdings were 11,040 shares.
UnitedHealth Group Chief Executive Officer, UHC, Timothy John Noel reported a tax-related share disposition under a Form 4. On 02/13/2026, 125.616 shares of UnitedHealth Group common stock were used to cover tax withholding at a price of $293.19 per share. Following this tax-withholding disposition, he directly owned 9,205.052 shares of common stock.
UnitedHealth Group executive Patrick H. Conway, Chief Executive Officer of Optum, reported a tax-related share disposition. On February 13, 2026, a Form 4 shows a code F tax-withholding disposition of 295.409 shares of UnitedHealth Group common stock at $293.19 per share. After this transaction, Conway directly beneficially owned 10,308.506 shares of common stock.
UnitedHealth Group Incorporated furnished a current report announcing that it has issued a press release with its fourth quarter and full year 2025 results. The press release is provided as Exhibit 99.1, and a hyperlinked PDF version is provided as Exhibit 99.2, both incorporated by reference in this report. The company also notes that the information under the results section is being furnished, not filed, so it is not automatically subject to certain liability provisions or incorporated into other securities law filings unless specifically referenced.
UnitedHealth Group Incorporated reports that its senior management team will meet with investors on January 12, 2026 and intends to reaffirm the company’s adjusted 2025 earnings per share expectations that were previously communicated on October 28, 2025. This indicates the company is currently standing by its earlier profit outlook for 2025.
The company also explains that its financial closing procedures for full-year 2025 are not yet complete, so actual results may change as closing activities, final adjustments, management review, and other developments occur. It cautions that final 2025 results could ultimately fall outside the previously discussed ranges, underscoring that this is a reaffirmation of expectations rather than a report of final earnings.
UnitedHealth Group director equity compensation reported
A Form 4 reports that director Paul R. Garcia received equity-based compensation from UnitedHealth Group Inc. (UNH) on 01/02/2026. The filing shows a grant of 168 deferred stock units at a price of $0, described as regular quarterly compensation for Board service. These deferred stock units are immediately vested but must be held until his Board service ends. The filing also shows a separate grant of 112 shares of common stock at $0, also as regular quarterly director compensation. Following these transactions, he beneficially owns UnitedHealth Group common stock directly and indirectly, including shares held through several trusts.
UnitedHealth Group director reports quarterly equity compensation grant
A UnitedHealth Group director reported receiving 285 shares of common stock on 01/02/2026 at a price of $0, reflecting a grant of deferred stock units as regular quarterly compensation for Board service. After this grant, the director beneficially owns 10,160 shares directly and 6,033 shares indirectly through a trust. The deferred stock units are immediately vested but must be held until the director’s service on the Board is completed.
UnitedHealth Group reported an insider equity transaction involving one of its directors. On 01/02/2026, the director received 168 shares of common stock, described as a regular quarterly compensation grant for board service. The shares were acquired at a stated price of $0, reflecting that they are part of non-cash director compensation rather than an open-market purchase.
Following this grant, the director beneficially owns 2,075 shares of UnitedHealth Group common stock directly and 3,800 shares indirectly through a trust. The filing records the transaction as an acquisition of common stock and confirms it is being reported by a single reporting person.
UnitedHealth Group director reports quarterly equity compensation. Director John H. Noseworthy M.D., a board member of UnitedHealth Group Inc., reported receiving 261 shares of common stock on 01/02/2026 at a stated price of $0.
According to the disclosure, these are deferred stock units granted as regular quarterly compensation for service as a director. The units are immediately vested but must be held until the director’s service on the Board is completed. After this grant, the director beneficially owns 6,997 shares directly.
UnitedHealth Group director reports quarterly equity grant
A director of UnitedHealth Group received 279 deferred stock units of common stock on 01/02/2026 as regular quarterly compensation for Board service. These deferred stock units vest immediately but must be held until the director’s service on the Board is completed. Following this grant, the director beneficially owns a total of 7,219 shares or units of UnitedHealth Group common stock, held directly.